Tag Archives: BIO 2014 Business Development and Finance

Why We Do This Work

rachel-king

In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Wanted: Tax Policies to Support Innovation

Research

Innovative small businesses work to advance research, development, and manufacturing of technologies to help solve economic, environmental, and societal challenges. The Coalition of Small Business Innovators is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small companies focusing on the development of transformative, life-changing new technologies. Small business innovators are working every day to solve the greatest challenges facing our society – whether it’s finding a cure for cancer, developing Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

De-Mystifying Trade Agreements

shutterstock_13529329

To many people in our industry, international trade agreements may seem like esoteric documents that have little relevance to the day-to-day workings of a research-based, innovative enterprise. After all, aren’t these agreements more about the cross-border trade of big-ticket goods like autos and wheat than they are about new, cutting edge technologies? Well, actually no. Those who have been paying close attention know that these agreements define many of the underlying rules of the road Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Principles on Clinical Trial Data Sharing Reaffirm Commitment

cells115x76

BIO member companies will honor, at minimum, the following commitments: REGISTERING CLINICAL TRIALS: BIO member companies will register all company-sponsored clinical trials conducted in patients in an appropriate public registry, such as ClinicalTrials.gov or the European Clinical Trials Database (EudraCT). SUMMARIZING THE RESULTS OF CLINICAL TRIALS: BIO member companies will post technical summary results in a clinical trials database as follows: For approved products, all company sponsored clinical trials testing both safety and efficacy in Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Therapeutic Licensing and M&A Deals

lab_tech

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least eight years for deals with disclosed values totaling over $10M. Total upfront payments to biotechs were also at an eight year low, with only $1.9B paid to biotechs in 2013. This is a 50 percent drop from peak levels. However, there is a silver lining in the data: Preclinical deal volume saw a slight increase in 2013, and has not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,